Optimal anticoagulation strategy for atrial fibrillation ablation: are all direct oral anticoagulants and vitamin K antagonists the same? - a meta-analysis of embolic and bleeding complications in more than 31,500 patients

Joglar JA Chung MK Armbruster AL 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines . Circulation . 2024 ; 149 ( 1 ): e1 - e156 . 10.1161/CIR.0000000000001193

Dorbala S Cohen AJ Hutchinson LA Menchavez-Tan E Steinberg JS. Does radiofrequency ablation induce a prethrombotic state? Analysis of coagulation system activation and comparison to electrophysiologic study . J Cardiovasc Electrophysiol . 1998 ; 9 ( 11 ): 1152 - 1160 . 10.1111/j.1540-8167.1998.tb00086.x

Khan IA. Transient atrial mechanical dysfunction (stunning) after cardioversion of atrial fibrillation and flutter . Am Heart J . 2002 ; 144 ( 1 ): 11 - 22 . 10.1067/mhj.2002.123113

Sparks PB Jayaprakash S Vohra JK Left atrial “stunning” following radiofrequency catheter ablation of chronic atrial flutter . J Am Coll Cardiol . 1998 ; 32 ( 2 ): 468 - 475 . 10.1016/S0735-1097(98)00253-8

Takami M Suzuki M Sugi K Ikeda T. Time course for resolution of left atrial appendage stunning after catheter ablation of chronic atrial flutter . J Am Coll Cardiol . 2003 ; 41 ( 12 ): 2207 - 2211 . 10.1016/S0735-1097(03)00496-0

Di Biase L Burkhardt JD Santangeli P Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management . Circulation . 2014 ; 129 ( 25 ): 2638 - 2644 . 10.1161/CIRCULATIONAHA.113.006426

Santangeli P Di Biase L Horton R Ablation of atrial fibrillation under therapeutic warfarin reduces periprocedural complications . Circ Arrhythm Electrophysiol . 2012 ; 5 ( 2 ): 302 - 311 . 10.1161/CIRCEP.111.964916

Connolly SJ Ezekowitz MD Yusuf S Dabigatran versus warfarin in patients with atrial fibrillation . N Engl J Med . 2009 ; 361 ( 12 ): 1139 - 1151 . 10.1056/NEJMoa0905561

Granger CB Alexander JH McMurray JJV Apixaban versus warfarin in patients with atrial fibrillation . N Engl J Med . 2011 ; 365 ( 11 ): 981 - 992 . 10.1056/NEJMoa1107039

Patel MR Mahaffey KW Garg J Rivaroxaban versus warfarin in nonvalvular atrial fibrillation . N Engl J Med . 2011 ; 365 ( 10 ): 883 - 891 . 10.1056/NEJMoa1009638

Giugliano RP Ruff CT Braunwald E Edoxaban versus warfarin in patients with atrial fibrillation . N Engl J Med . 2013 ; 369 ( 22 ): 2093 - 2104 . 10.1056/NEJMoa1310907

Gómez-Outes A Alcubilla P Calvo-Rojas G Meta-analysis of reversal agents for severe bleeding associated with direct oral anticoagulants . J Am Coll Cardiol . 2021 ; 77 ( 24 ): 2987 - 3001 . 10.1016/j. jacc.2021.04.061

Konduru SV Cheema AA Jones P Li Y Ramza B Wimmer AP. Differences in intraprocedural ACTs with standardized heparin dosing during catheter ablation for atrial fibrillation in patients treated with dabigatran vs. patients on uninterrupted warfarin . J Interv Card Electrophysiol . 2012 ; 35 ( 3 ): 277 - 284 . 10.1007/s10840-012-9719-9

Tao S Otomo K Ono Y Efficacy and safety of uninterrupted rivaroxaban taken preoperatively for radiofrequency catheter ablation of atrial fibrillation compared to uninterrupted warfarin . J Interv Card Electrophysiol . 2017 ; 48 ( 2 ): 167 - 175 . 10.1007/s10840-016-0214-6

Lakkireddy D Reddy YM Di Biase L Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry . J Am Coll Cardiol . 2012 ; 59 ( 13 ): 1168 - 1174 . 10.1016/j.jacc.2011.12.014

Ichiki H Oketani N Ishida S The incidence of asymptomatic cerebral microthromboembolism after atrial fibrillation ablation: comparison of warfarin and dabigatran . Pacing Clin Electrophysiol . 2013 ; 36 ( 11 ): 1328 - 1335 . 10.1111/pace.12195

Hohnloser SH Camm J Cappato R Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial . Eur Heart J . 2019 ; 40 ( 36 ): 3013 - 3021 . 10.1093/eurheartj/ehz190

Armbruster HL Lindsley JP Moranville MP Safety of novel oral anticoagulants compared with uninterrupted warfarin for catheter ablation of atrial fibrillation . Ann Pharmacother . 2015 ; 49 ( 3 ): 278 - 284 . 10.1177/1060028014563950

Arshad A Johnson CK Mittal S Comparative safety of periablation anticoagulation strategies for atrial fibrillation: data from a large multicenter study . Pacing Clin Electrophysiol . 2014 ; 37 ( 6 ): 665 - 673 . 10.1111/pace.12401

Bassiouny M Saliba W Rickard J Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation . Circ Arrhythm Electrophysiol . 2013 ; 6 ( 3 ): 460 - 466 . 10.1161/CIRCEP.113.000320

Calkins H Willems S Gerstenfeld EP Uninterrupted dabigatran versus warfarin for ablation in atrial fibrillation . N Engl J Med . 2017 ; 376 ( 17 ): 1627 - 1636 . 10.1056/NEJMoa1701005

Cappato R Marchlinski FE Hohnloser SH Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation . Eur Heart J . 2015 ; 36 ( 28 ): 1805 - 1811 . 10.1093/eurheartj/ehv177

De Heide J Vroegh CJ Bhagwandien RE Minimally interrupted novel oral anticoagulant versus uninterrupted vitamin K antagonist during atrial fibrillation ablation . J Interv Card Electrophysiol . 2018 ; 53 ( 3 ): 341 - 346 . 10.1007/s10840-018-0417-0

Di Biase L Lakkireddy D Trivedi C Feasibility and safety of uninterrupted periprocedural apixaban administration in patients undergoing radiofrequency catheter ablation for atrial fibrillation: results from a multicenter study . Heart Rhythm . 2015 ; 12 ( 6 ): 1162 - 1168 . 10.1016/j.hrthm.2015.02.028

Dillier R Ammar S Hessling G Safety of continuous periprocedural rivaroxaban for patients undergoing left atrial catheter ablation procedures . Circ Arrhythm Electrophysiol . 2014 ; 7 ( 4 ): 576 - 582 . 10.1161/CIRCEP.114.001586

Efremidis M Vlachos K Letsas KP Low dose dabigatran versus uninterrupted acenocoumarol for peri-procedural anticoagulation in atrial fibrillation catheter ablation . J Electrocardiol . 2015 ; 48 ( 5 ): 840 - 844 . 10.1016/j.jelectrocard.2015.06.011

Enriquez AD Churchill T Gautam S Determinants of heparin dosing and complications in patients undergoing left atrial ablation on uninterrupted rivaroxaban . Pacing Clin Electrophysiol . 2017 ; 40 ( 2 ): 183 - 190 . 10.1111/pace.13013

Garcia L Mascarenhas MA Ahuja K The safety of dabigatran versus warfarin in patients undergoing atrial fibrillation ablation . J Atr Fibrillation . 2014 ; 6 ( 5 ): 20 - 24 . 10.4022/jafib.965

Gjermeni D Saglam NP Olivier CB Kühlkamp V. Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillation . Eur Heart J Open . 2023 ; 3 ( 4 ): oead065 . 10.1093/ehjopen/oead065

Gunawardene M Willems S Schäffer B Influence of periprocedural anticoagulation strategies on complication rate and hospital stay in patients undergoing catheter ablation for persistent atrial fibrillation . Clin Res Cardiol . 2017 ; 106 ( 1 ): 38 - 48 . 10.1007/s00392-016-1021-x

Haines DE Mead-Salley M Salazar M Dabigatran versus warfarin anticoagulation before and after catheter ablation for the treatment of atrial fibrillation . J Interv Card Electrophysiol . 2013 ; 37 ( 3 ): 233 - 239 . 10.1007/s10840-013-9800-z

Imamura K Yoshida A Takei A Dabigatran in the periprocedural period for radiofrequency ablation of atrial fibrillation: efficacy, safety, and impact on duration of hospital stay . J Interv Card Electrophysiol . 2013 ; 37 ( 3 ): 223 - 231 . 10.1007/s10840-013-9801-y

Kaess BM Ammar S Reents T Comparison of safety of left atrial catheter ablation procedures for atrial arrhythmias under continuous anticoagulation with apixaban versus phenprocoumon . Am J Cardiol . 2015 ; 115 ( 1 ): 47 - 51 . 10.1016/j.amjcard.2014.10.005

Kaiser DW Streur MM Nagarakanti R Whalen SP Ellis CR. Continuous warfarin versus periprocedural dabigatran to reduce stroke and systemic embolism in patients undergoing catheter ablation for atrial fibrillation or left atrial flutter . J Interv Card Electrophysiol . 2013 ; 37 ( 3 ): 241 - 247 . 10.1007/s10840-013-9793-7

Kaseno K Naito S Nakamura K Efficacy and safety of periprocedural dabigatran in patients undergoing catheter ablation of atrial fibrillation . Circ J . 2012 ; 76 ( 10 ): 2337 - 2342 . 10.1253/circj.CJ-12-0498

Kim JS She F Jongnarangsin K Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation . Heart Rhythm . 2013 ; 10 ( 4 ): 483 - 489 . 10.1016/j.hrthm.2012.12.011

Kimura T Kashimura S Nishiyama T Asymptomatic cerebral infarction during catheter ablation for atrial fibrillation: comparing uninterrupted rivaroxaban and warfarin (ASCERTAIN) . JACC Clin Electrophysiol . 2018 ; 4 ( 12 ): 1598 - 1609 . 10.1016/j.jacep.2018.08.003

Kirchhof P Haeusler KG Blank B Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation . Eur Heart J . 2018 ; 39 ( 32 ): 2942 - 2955 . 10.1093/eurheartj/ehy176

Kochhäuser S Khaykin Y Beardsall J Comparison of outcomes after cardioversion or atrial fibrillation ablation in patients with differing periprocedural anticoagulation regimens . Can J Cardiol . 2014 ; 30 ( 12 ): 1541 - 1546 . 10.1016/j.cjca.2014.09.018

Koektuerk B Turan CH Yorgun H The total incidence of complications and the impact of an anticoagulation regime on adverse events after cryoballoon ablation of atrial fibrillation: a single-center study of 409 patients . Cardiovasc Ther . 2016 ; 34 ( 3 ): 144 - 151 . 10.1111/1755-5922.12178

Kuwahara T Abe M Yamaki M Apixaban versus warfarin for the prevention of periprocedural cerebral thromboembolism in atrial fibrillation ablation: multicenter prospective randomized study . J Cardiovasc Electrophysiol . 2016 ; 27 ( 5 ): 549 - 554 . 10.1111/jce.12928

Lakkireddy D Reddy YM Di Biase L Feasibility and safety of uninterrupted rivaroxaban for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry . J Am Coll Cardiol . 2014 ; 63 ( 10 ): 982 - 988 . 10.1016/j.jacc.2013.11.039

Lin J Shen S Bhave PD Post-procedural dabigatran versus standard anticoagulation in ablation for atrial fibrillation . J Atr Fibrillation . 2014 ; 6 ( 5 ): 10 - 14 . 10.4022/jafib.1000

Maddox W Kay GN Yamada T Dabigatran versus warfarin therapy for uninterrupted oral anticoagulation during atrial fibrillation ablation . J Cardiovasc Electrophysiology . 2013 ; 24 ( 8 ): 861 - 865 . 10.1111/jce.12143

Mugnai G de Asmundis C Iacopino S Comparison of the incidences of complications after second-generation cryoballoon ablation of atrial fibrillation using vitamin K antagonists versus novel oral anticoagulants . Am J Cardiol . 2017 ; 120 ( 2 ): 223 - 229 . 10.1016/j.amjcard.2017.04.012

Müller P Halbfass P Szöllösi A Impact of periprocedural anticoagulation strategy on the incidence of new-onset silent cerebral events after radiofrequency catheter ablation of atrial fibrillation . J Interv Card Electrophysiol . 2016 ; 46 ( 3 ): 203 - 211 . 10.1007/s10840-016-0117-6

Murakawa Y Nogami A Shoda M Nationwide survey of catheter ablation for atrial fibrillation: the Japanese catheter ablation registry of atrial fibrillation (J-CARAF)–a report on periprocedural oral anticoagulants . J Arrhythm . 2015 ; 31 ( 1 ): 29 - 32 . 10.1016/j.joa.2014.05.003

Nagao T Inden Y Yanagisawa S Differences in activated clotting time among uninterrupted anticoagulants during the periprocedural period of atrial fibrillation ablation . Heart Rhythm . 2015 ; 12 ( 9 ): 1972 - 1978 . 10.1016/j.hrthm.2015.04.016

Nagao T Inden Y Shimano M Efficacy and safety of apixaban in the patients undergoing the ablation of atrial fibrillation . Pacing Clin Electrophysiol . 2015 ; 38 ( 2 ): 155 - 163 . 10.1111/pace.12553

Nagao T Inden Y Shimano M Feasibility and safety of uninterrupted dabigatran therapy in patients undergoing ablation for atrial fibrillation . Intern Med . 2015 ; 54 ( 10 ): 1167 - 1173 . 10.2169/internalmedicine.54.3520

Nin T Sairaku A Yoshida Y A randomized controlled trial of dabigatran versus warfarin for periablation anticoagulation in patients undergoing ablation of atrial fibrillation . Pacing Clin Electrophysiol . 2013 ; 36 ( 2 ): 172 - 179 . 10.1111/pace.12036

Nogami A Harada T Sekiguchi Y Safety and efficacy of minimally interrupted dabigatran vs uninterrupted warfarin therapy in adults undergoing atrial fibrillation catheter ablation: A randomized clinical trial . JAMA Netw Open . 2019 ; 2 ( 4 ): e191994 . 10.1001/jamanetworkopen.2019.1994

Okishige K Nakamura T Aoyagi H Comparative study of hemorrhagic and ischemic complications among anticoagulants in patients undergoing cryoballoon ablation for atrial fibrillation . J Cardiol . 2017 ; 69 ( 1 ): 11 - 15 . 10.1016/j.jjcc.2016.04.009

Reynolds MR Allison JS Natale A A prospective randomized trial of apixaban dosing during atrial fibrillation ablation: The AEIOU trial . JACC Clin Electrophysiol . 2018 ; 4 ( 5 ): 580 - 588 . 10.1016/j.jacep.2017.11.005

Rillig A Lin T Plesman J Apixaban, rivaroxaban, and dabigatran in patients undergoing atrial fibrillation ablation . J Cardiovasc Electrophysiol . 2016 ; 27 ( 2 ): 147 - 153 . 10.1111/jce.12856

Snipelisky D Kauffman C Prussak K Johns G Venkatachalam K Kusumoto F. A comparison of bleeding complications post-ablation between warfarin and dabigatran . J Interv Card Electrophysiol . 2012 ; 35 ( 1 ): 29 - 33 . 10.1007/s10840-012-9708-z

Snipelisky D Ray JC Ung R Duart M Kauffman C Kusumoto F. A comparison of bleeding complications between warfarin dabigatran, and rivaroxaban in patients undergoing cryoballoon ablation . J Interv Card Electrophysiol . 2014 ; 41 ( 3 ): 231 - 236 . 10.1007/s10840-014-9948-1

Somani R Mohajer K Haley C The peri-procedural use of dabigatran in patients undergoing left atrial ablation for atrial fibrillation . Cardiovasc Ther . 2014 ; 32 ( 5 ): 198 - 201 . 10.1111/1755-5922.12082

Stepanyan G Badhwar N Lee RJ Safety of new oral anticoagulants for patients undergoing atrial fibrillation ablation . J Interv Card Electrophysiol . 2014 ; 40 ( 1 ): 33 - 38 . 10.1007/s10840-014-9888-9

Tang L Liu H Deng H Minimally interrupted non-vitamin K antagonist oral anticoagulants vs. bridging therapy and uninterrupted vitamin K antagonists during atrial fibrillation ablation : A retrospective single-center study. Front Med . 2020 ; 7

Tscholl V Lsharaf AKA Lin T Apixaban, rivaroxaban, and dabigatran use in patients undergoing catheter ablation for atrial fibrillation using the second-generation cryoballoon . Clin Cardiol . 2017 ; 40 ( 11 ): 1095 - 1099 . 10.1002/clc.22782

Vlachos K Efremidis M Bazoukis G Safety and efficacy of DOACS vs acenocoumarol in patients undergoing catheter ablation of atrial fibrillation . Clin Cardiol . 2017 ; 40 ( 10 ): 847 - 852 . 10.1002/clc.22734

Yamaji H Murakami T Hina K Usefulness of dabigatran etexilate as periprocedural anticoagulation therapy for atrial fibrillation ablation . Clin Drug Investig . 2013 ; 33 ( 6 ): 409 - 418 . 10.1007/s40261-013-0081-1

Yanagisawa S Inden Y Fujii A Uninterrupted direct oral anticoagulant and warfarin administration in elderly patients undergoing catheter ablation for atrial fibrillation: a comparison with younger patients . JACC Clin Electrophysiol . 2018 ; 4 ( 5 ): 592 - 600 . 10.1016/j. jacep.2018.02.013

Yoshimura A Iriki Y Ichiki H Evaluation of safety and efficacy of periprocedural use of rivaroxaban and apixaban in catheter ablation for atrial fibrillation . J Cardiol . 2017 ; 69 ( 1 ): 228 - 235 . 10.1016/j.jjcc.2016.03.014

Berkman ND Lohr KN Ansari MT Grading the strength of a body of evidence when assessing health care interventions: an EPC update . J Clin Epidemiol . 2015 ; 68 ( 11 ): 1312 - 1324 . 10.1016/j.jclinepi.2014.11.023

Sterne JAC Sutton AJ Ioannidis JPA Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials . BMJ . 2011 ; 343 : d4002 . 10.1136/bmj.d4002

Winkle RA. Atrial fibrillation ablation in patients with transvenous devices: safety and insights into getting rid of the 30-second rule defining procedural success . J Cardiovasc Electrophysiol . 2019 ; 30 ( 5 ): 688 - 690 . 10.1111/jce.13892

van Vugt SPG Westra SW Volleberg RHJA Meta-analysis of controlled studies on minimally interrupted vs. continuous use of nonvitamin K antagonist oral anticoagulants in catheter ablation for atrial fibrillation . EP Europace . 2021 ; 23 ( 12 ): 1961 - 1969 . 10.1093/europace/euab175

Steinberg BA Hasselblad V Atwater BD Dabigatran for periprocedural anticoagulation following radiofrequency ablation for atrial fibrillation: a meta-analysis of observational studies . J Interv Card Electrophysiol . 2013 ; 37 ( 3 ): 213 - 221 . 10.1007/s10840-013-9813-7

Providência R Albenque JP Combes S Safety and efficacy of dabigatran versus warfarin in patients undergoing catheter ablation of atrial fibrillation: A systematic review and meta-analysis. Heart . 2014 ; 100 ( 4 ): 324 . 10.1136/heartjnl-2013-304386

Shurrab M Morillo CA Schulman S Safety and efficacy of dabigatran compared with warfarin for patients undergoing radiofrequency catheter ablation of atrial fibrillation: A meta-analysis . Can J Cardiol . 2013 ; 29 ( 10 ): 1203 - 1210 . 10.1016/j.cjca.2013.07.005

Hohnloser SH Camm AJ. Safety and efficacy of dabigatran etexilate during catheter ablation of atrial fibrillation: A meta-analysis of the literature . EP Europace . 2013 ; 15 ( 10 ): 1407 - 1411 . 10.1093/europace/eut241

Bin Abdulhak AA Khan AR Tleyjeh IM Safety and efficacy of interrupted dabigatran for peri-procedural anticoagulation in catheter ablation of atrial fibrillation: A systematic review and meta-analysis . EP Europace . 2013 ; 15 ( 10 ): 1412 - 1420 . 10.1093/europace/eut239

Aryal MR Ukaigwe A Pandit A Meta-analysis of efficacy and safety of rivaroxaban compared with warfarin or dabigatran in patients undergoing catheter ablation for atrial fibrillation . Am J Cardiol . 2014 ; 114 ( 4 ): 577 - 582 . 10.1016/j.amjcard.2014.05.038

Phan K Wang N Pison L Kumar N Hitos K Thomas SP. Meta-Analysis of dabigatran vs warfarin in patients undergoing catheter ablation for atrial fibrillation. Int J Cardiol . 2015 ; 189 : 199 - 203 . 10.1016/j. ijcard.2015.04.072

Phan K Wang N Pison L Kumar N Hitos K Thomas SP. Rivaroxaban versus warfarin or dabigatran in patients undergoing catheter ablation for atrial fibrillation: a meta-analysis . Int J Cardiol . 2015 ; 185 : 209 - 213 . 10.1016/j.ijcard.2015.03.102

Piccini JP Stevens SR Lokhnygina Y Outcomes after cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial . J Am Coll Cardiol . 2013 ; 61 ( 19 ): 1998 - 2006 . 10.1016/j.jacc.2013.02.025

Ukaigwe A Shrestha P Karmacharya P Meta-analysis of efficacy and safety of apixaban and uninterrupted apixaban therapy compared to vitamin K antagonists in patients undergoing catheter ablation for atrial fibrillation . J Interv Card Electrophysiol . 2017 ; 48 ( 2 ): 223 - 233 . 10.1007/s10840-016-0195-5

Lu D Liu Q Wang K Zhang Q Shan QJ. Meta-analysis of efficacy and safety of apixaban in patients undergoing catheter ablation for atrial fibrillation . Pacing Clin Electrophysiol . 2016 ; 39 ( 1 ): 54 - 59 . 10.1111/pace.12771

Blandino A Bianchi F Biondi-Zoccai G Apixaban for periprocedural anticoagulation during catheter ablation of atrial fibrillation: a systematic review and meta-analysis of 1691 patients . J Interv Card Electrophysiol . 2016 ; 46 ( 3 ): 225 - 236 . 10.1007/s10840-016-0141-6

Bawazeer G Alkofide H Alsharafi A Interrupted versus uninterrupted anticoagulation therapy for catheter ablation in adults with arrhythmias . Cochrane Database Syst Rev . 2021 ;( 10 ). 10.1002/14651858.CD013504.pub2

Winkle RA Mead RH Engel G Kong MH Patrawala RA. Periprocedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin warfarin, dabigatran, and rivaroxaban . EP Europace . 2014 ; 16 ( 10 ): 1443 - 1449 . 10.1093/europace/euu196

Nakamura K Naito S Sasaki T Uninterrupted vs. interrupted periprocedural direct oral anticoagulants for catheter ablation of atrial fibrillation: a prospective randomized single-centre study on post-ablation thrombo-embolic and haemorrhagic events . EP Europace . 2019 ; 21 ( 2 ): 259 - 267 . 10.1093/europace/euy148